ANDA 88803, held by Hikma. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 88803 (Lidocaine Hydrochloride), held by Hikma, was first approved by FDA on Apr 3, 1985, with 12 approved supplements and 0 published complete response letters.
INDICATIONS Lidocaine hydrochloride is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 3, 1985 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lidocaine Hydrochloride4% · solution;topical | Lidocaine Hydrochloride | Rx |
| Aug 20, 2021 | Supplement 17Labeling · Standard review | Approved | None posted |
| Jun 30, 2008 | Supplement 13Labeling | Approved | None posted |
| Mar 27, 2000 | Supplement 9Manufacturing | Approved | None posted |
| Mar 27, 2000 | Supplement 10Manufacturing | Approved | None posted |
| Aug 28, 1996 | Supplement 8Manufacturing | Approved | None posted |
| Jun 18, 1991 | Supplement 7Labeling | Approved | None posted |
| Mar 4, 1991 | Supplement 6Manufacturing | Approved | None posted |
| Aug 31, 1989 | Supplement 5Labeling | Approved | None posted |
| Nov 1, 1988 | Supplement 2Bioequivalence | Approved | None posted |
| Oct 17, 1988 | Supplement 1Labeling | Approved | None posted |
| Sep 27, 1988 | Supplement 3Manufacturing | Approved | None posted |
| Sep 27, 1988 | Supplement 4Manufacturing | Approved | None posted |
| Apr 3, 1985 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters